“The first quarter of the financial year of 2016 had been encouraging as we continued to deliver strong results by focussing on operational efficiency and showing improvement in margin profile of the company. During this quarter, we have further strengthened our footings towards introduction of newer molecules to increase our product portfolio,” C Krishna Prasad, chairman and managing director, stated in a release.
The company was able to improve the EBITDA margins by 137 basis points compared to the corresponding previous quarter.
Granules scrip rose 4.92% at Rs 102.45 on Bombay Stock Exchange on Thursday.